Histotype
Mammary/Breast
| Parameter | Information |
|---|---|
| Strain | SCID beige |
| Implant Type | Cells |
| Implant Location | Mammary Fat Pad |
| Time to Staging | 14 days |
| Time to 750mm3 | 28.9 days |
| Td | 6.6 days |
The above parameters are from one study. For further information on this cell line and other parameters, including different strains, vendors, implant type and location and/or standards of care, please contact us.
Tumor Line
Human
Ref #
1968
Spotlight on MDA-MB-231-Luc-D3H2LN
Learn more about this cell line in our scientific spotlights:
Breast cancer is the most common non-skin cancer among women. One in eight women will develop invasive breast cancer during her lifetime, and about 10-20% of those women (more than one out of every 10) will be diagnosed with a triple-negative sub-type (ER-, PR- and HER2-). There is intense interest in developing new drugs that can treat this kind of breast cancer. Unfortunately, there are only a few preclinical models that mimic this expression profile.